cbdMD, Inc. (YCBD) Insider Trading Activity

AMEX$0.6399
Market Cap
$5.7M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
823 of 827
Rank in Industry
49 of 50

YCBD Insider Trading Activity

YCBD Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About cbdMD, Inc.

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.

Insider Activity of cbdMD, Inc.

Over the last 12 months, insiders at cbdMD, Inc. have bought $0 and sold $0 worth of cbdMD, Inc. stock.

On average, over the past 5 years, insiders at cbdMD, Inc. have bought $12,798 and sold $2.86M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,000 shares for transaction amount of $10,500 was made by Kennedy Thomas Ronan (Interim CEO and CFO) on 2023‑05‑03.

List of Insider Buy and Sell Transactions, cbdMD, Inc.

2023-05-03PurchaseKennedy Thomas RonanInterim CEO and CFO
5,000
18.1948%
$2.10
$10,500
-50.26%
2021-08-24PurchaseKennedy Thomas RonanCFO & COO
7,400
0.0135%
$2.04
$15,096
-52.09%
2021-03-11SaleSumichrast Martin A.Chairman & CO-CEO
65,493
0.0024%
$3.93
$257,564
-52.73%
2021-03-10SaleSumichrast Martin A.Chairman & CO-CEO
59,507
0.0025%
$4.04
$240,117
-48.00%
2021-03-02SaleRaines William F IIIdirector
20,000
0.0008%
$4.04
$80,748
-46.46%
2021-02-22SaleCoffman Raymond ScottCO-CEO, President, Director
122,000
0.005%
$4.25
$518,805
-49.54%
2021-02-19SaleCoffman Raymond ScottCO-CEO, President, Director
3,000
0.0001%
$4.28
$12,846
-50.11%
2021-02-19SaleSumichrast Martin A.Chairman & CO-CEO
240,035
0.0099%
$4.42
$1.06M
-50.11%
2021-02-18SaleSumichrast Martin A.Chairman & CO-CEO
113,104
0.0048%
$4.43
$500,768
-48.26%
2021-02-17SaleSumichrast Martin A.Chairman & CO-CEO
42,461
0.0018%
$4.54
$192,764
-48.39%
2020-08-14SaleSellers Bakari T.director
10,000
0.0244%
$3.43
$34,300
-8.15%
2020-03-09PurchaseGhiloni Peter J.director
25,000
0.0014%
$0.75
$18,720
+200.75%
2020-01-27PurchaseElliott Mark SCFO & COO
5,000
0.0003%
$1.06
$5,300
+90.09%
2020-01-14PurchaseCoffman Raymond ScottCO-CEO
250,000
0.0145%
$1.00
$250,000
+88.57%
2020-01-14PurchaseSumichrast Martin A.CO-CEO
250,000
0.0145%
$1.00
$250,000
+88.57%
2020-01-14PurchaseGhiloni Peter J.director
250,000
0.0145%
$1.00
$250,000
+88.57%
2020-01-14PurchaseRaines William F IIIdirector
40,000
0.0023%
$1.00
$40,000
+88.57%
2020-01-14PurchaseElliott Mark SCFO & COO
15,000
0.0009%
$1.00
$15,000
+88.57%
2020-01-14PurchaseStephen Scott G.director
40,000
0.0023%
$1.00
$40,000
+88.57%
2020-01-14PurchaseMorris Gregory Cdirector
30,000
0.0017%
$1.00
$30,000
+88.57%
Total: 24

Insider Historical Profitability

86.29%
Sumichrast Martin A.Chairman & CO-CEO
1425344
15.9803%
$910,224.6817
+88.57%
Ghiloni Peter J.director
300000
3.3635%
$191,580.0020
+144.66%
Elliott Mark SCFO & COO
51680
0.5794%
$33,002.8520
+89.33%
Stephen Scott G.director
41052
0.4603%
$26,215.8110
+88.57%
Morris Gregory Cdirector
17531
0.1965%
$11,195.3010
+88.57%
Kennedy Thomas RonanInterim CEO and CFO
6462
0.0724%
$4,126.6320
<0.0001%
Sellers Bakari T.director
2531
0.0284%
$1,616.3011
+88.57%
Raines William F IIIdirector
1342
0.015%
$857.0011
+88.57%
Sterling Erik10 percent owner
0
0%
$001
Coffman Raymond ScottCO-CEO, President, Director
0
0%
$012
+88.57%

Historical Insider Profitability vs. Competitors

$2,074,051
1739
3.68%
$32.46M
$125,860,243
57
-4.48%
$31.23M
$2,767,882
51
8.70%
$27.32M
$30,218,950
47
-3.19%
$19.21M
$33,884,330
45
12.58%
$440.41M
$97,642,477
41
-10.58%
$451.79M
$3,140,759
30
10.79%
$6.21M
$423,174,478
29
-7.58%
$5.89M
$32,539,771
28
33.37%
$245.16M
$25,034,841
20
9.38%
$564.49M
cbdMD, Inc.
(YCBD)
$919,520
11
86.29%
$5.7M
$758,061
9
60.03%
$189.01M
$4,039,981
8
-3.44%
$12.42M
$8,171,353
7
-14.29%
$15.96M
$26,692
7
-31.27%
$26.47M
$148,823
6
-0.13%
$75.11M
$1,030,757
4
-32.95%
$4.99M
$12,203,133
3
25.43%
$280.97M
$10,000
1
-96.58%
$7.11M

YCBD Institutional Investors: Active Positions

Increased Positions8+36.36%82,562+17.01%
Decreased Positions6-27.27%131,631-27.13%
New Positions5New78,972New
Sold Out Positions4Sold Out130,013Sold Out
Total Postitions24+9.09%436,162-10.11%

YCBD Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Css Llc/Il$87.001.59%142,62100%2025-09-30
Chapin Davis, Inc.$74.001.35%121,551+2,925+2.47%2025-09-30
Alesco Advisors Llc$42.000.76%68,51300%2025-09-30
Vanguard Group Inc$31.000.57%51,563+51,563New2025-09-30
Commonwealth Equity Services, Llc$10.000.18%16,25500%2025-09-30
Scientech Research Llc$9.000.17%15,406+15,406New2025-09-30
Sassicaia Capital Advisers Llc$7.000.13%12,000+12,000New2025-09-30
Harbour Investments, Inc.$3.000.06%5,20000%2025-09-30
Morgan Stanley$1.000.01%1,13900%2025-09-30
Blackrock, Inc.$1.000.01%1,080-34-3.05%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.